MedTrace Logo

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

NCT03997838 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 307

Last updated 2020-08-25

No results posted yet for this study

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.

Conditions

  • Pain, Postoperative

Interventions

DRUG

VVZ-149 Injections

IV infusion of 1000 mg of VVZ-149

DRUG

Placebo

IV infusion of 0 mg of VVZ-149

Sponsors & Collaborators

  • Vivozon, Inc.

    lead INDUSTRY

Principal Investigators

  • Doo Lee, PhD · Vivozon, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-23
Primary Completion
2019-08-03
Completion
2019-08-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03997838 on ClinicalTrials.gov